Golden
Topic: Cofactor GenomicsCofactor Genomics

A company using RNA to diagnose disease and to develop biomarkers that predict treatment outcomes. Cofactor is founded by Jarret Glasscock.

  • Suggestion Id: 487134

Would it be accurate and relevant to link the text highlighted below to the topic SolidSolid?

Solid tumor samples can be sent to Cofactor for analysis using the ImmunoPrism Assay and individual samples are compared to the Health Expression Models database which represents key immune cell types. An ImmunoPrism Report is generated for each patient. When clinical outcome data is available for patient cohorts, their Predictive Immune Modeling platform will generate a multidimensional biomarker. The platform uses machine-learning.

Topic: Universal CellsUniversal Cells

Universal Cells is a biotechnology company developing regenerative medicine using stem cells.

  • Suggestion Id: 487132

Would it be accurate and relevant to link the text highlighted below to the topic SeattleSeattle?

Universal Cells is a biotechnology company developing regenerative medicine using stem cells that is headquartered in Seattle, Washington and was founded in 2013 by Claudia Mitchell and David Russell. On February 13, 2018 Universal Cells was acquired by Astellas Pharma for an undisclosed amount. 

Topic: Universal CellsUniversal Cells

Universal Cells is a biotechnology company developing regenerative medicine using stem cells.

  • Suggestion Id: 487131

Would it be accurate and relevant to link the text highlighted below to the topic Astellas PharmaAstellas Pharma?

Universal Cells is a biotechnology company developing regenerative medicine using stem cells that is headquartered in Seattle, Washington and was founded in 2013 by Claudia Mitchell and David Russell. On February 13, 2018 Universal Cells was acquired by Astellas Pharma for an undisclosed amount. 

Topic: Cofactor GenomicsCofactor Genomics

A company using RNA to diagnose disease and to develop biomarkers that predict treatment outcomes. Cofactor is founded by Jarret Glasscock.

  • Suggestion Id: 487136

Would it be accurate and relevant to link the text highlighted below to the topic CollegeCollege?

The ImmunoPrism (formerly called Paragon) assay completed validation and certification by the College of American Pathologists (CAP) in 2018. Cofactor’s ImmunoPrism Immune Profiling Kit was launched in 2018, which gives laboratories access to the same kit the company uses for sample preparation, sequencing and analysis of tumor samples. 

Topic: Cofactor GenomicsCofactor Genomics

A company using RNA to diagnose disease and to develop biomarkers that predict treatment outcomes. Cofactor is founded by Jarret Glasscock.

  • Suggestion Id: 487133

Would it be accurate and relevant to link the text highlighted below to the topic RNARNA?

Cofactor Genomics analyzes the presence, absence of RNA and dynamic levels of gene expression. Genes that are expressed are active and transcribe RNA. Gene expression levels can be influenced by factors including the state of disease, environmental effects and therapy. Cofactor has built Health Expression Models, which are gene expression profiles for key immune cell types. 

Topic: Cofactor GenomicsCofactor Genomics

A company using RNA to diagnose disease and to develop biomarkers that predict treatment outcomes. Cofactor is founded by Jarret Glasscock.

  • Suggestion Id: 487137

Would it be accurate and relevant to link the text highlighted below to the topic RNA sequencingRNA sequencing?

Cofactor provides a range of RNA sequencing services.

Topic: Xerion HealthcareXerion Healthcare

Company developing nanoparticles to improve radiotherapy cancer treatments.

  • Suggestion Id: 486857

Would it be accurate and relevant to link the text highlighted below to the topic HighHigh?

Radiotherapy effectiveness partly relies on molecular oxygen. High energy X-ray photons generate electrons that scatter within the tumor and interact with molecular oxygen to produce superoxide radicals which damage tumor cells. Radiotherapy is less effective in areas of a tumor that are low in oxygen. Xerion Healthcare is addressing this problem with their nanoparticles which are able to generate free radicals by splitting water rather then by interacting with oxygen. 

Topic: CRISPR-ChipCRISPR-Chip

A hand-held device that quickly detects specific genetic mutations by using CRISPR combined with graphene based electronic transistors.

  • Suggestion Id: 487142

Would it be accurate and relevant to link the text highlighted below to the topic UniversityUniversity?

CRISPR-Chip, the first transistor that uses CRISPR to search the genome for mutations, was developed by researchers at University of California, Berkeley and the Keck Graduate Institute (KGI) of The Claremont Colleges. Their invention was reported in Nature Biomedical Engineering in March, 2019 and assistant professor at KGI is Kiana Aran. 

Topic: CRISPR-ChipCRISPR-Chip

A hand-held device that quickly detects specific genetic mutations by using CRISPR combined with graphene based electronic transistors.

  • Suggestion Id: 487143

Would it be accurate and relevant to link the text highlighted below to the topic CaliforniaCalifornia?

CRISPR-Chip, the first transistor that uses CRISPR to search the genome for mutations, was developed by researchers at University of California, Berkeley and the Keck Graduate Institute (KGI) of The Claremont Colleges. Their invention was reported in Nature Biomedical Engineering in March, 2019 and assistant professor at KGI is Kiana Aran. 

Topic: Cluster: Educational technologyCluster: Educational technology

A cluster of topics related to the use of technology in education to improve learning and teaching.

  • Suggestion Id: 487113

Would it be accurate and relevant to link the text highlighted below to the topic Emerge EducationEmerge Education?

  • Emerge Education
  • Topic: NCINCI

    French private equity and venture capital firm investing on French companies.

    • Suggestion Id: 487127

    Would it be accurate and relevant to link the text highlighted below to the topic Venture capital firmVenture capital firm?

    NCI is a private equity and venture capital firm established in 1999. The firm is based from Rouen, France. As of March 2019, the firm has 59 companies in its portfolio and has sold off its ownership in 58 companies.

    Topic: CRISPR-ChipCRISPR-Chip

    A hand-held device that quickly detects specific genetic mutations by using CRISPR combined with graphene based electronic transistors.

    • Suggestion Id: 487138

    Would it be accurate and relevant to link the text highlighted below to the topic RNARNA?

    The device analyses purified DNA and gives a report in minutes. The speed comes from the fact that unlike most forms of genetic testing, CRISPR-Chip does not PCR amplify the DNA. The device uses a form of the CRISPR-Cas9 system with a deactivated Cas9 that does not cut. Guide RNA, complementary to the target DNA sequence guides Cas9 to the find exact location in the genome where it binds. In the device Cas9 is tethered to transistors made of graphene, which undergoes a change in electrical conductance when Cas9 binds to the target DNA. The resultant changes in the characteristics of the transistor are detectable in the hand-held device. Graphene is made of a single layer of carbon atoms and is electrically sensitive. In genomic DNA CRISPR-Chip detects a target in 15 minutes with 1.7fM sensitivity.

    Topic: GE VenturesGE Ventures

    U.S-based venture capital firm funding startups and early-stage companies globally.

    • Suggestion Id: 487125

    Would it be accurate and relevant to link the text highlighted below to the topic Venture capital firmVenture capital firm?

    GE Ventures is a venture capital firm established since 2013. The firm is a subsidiary of General Electric. The firm primarily operates from Menlo Park, California, although it also has offices in Boston, Massachusetts; Houston, Texas; Chicago, Illinois; Shanghai, China; and Tel Aviv, Israel. As of February 2019, the firm manages 118 companies in its portfolio and has sold off its shares in 60 companies. Its most recent investment was for Xage Security in January 2019, a company providing block-chain protected security platform services.

    Topic: Universal CellsUniversal Cells

    Universal Cells is a biotechnology company developing regenerative medicine using stem cells.

    • Suggestion Id: 487130

    Would it be accurate and relevant to link the text highlighted below to the topic Claudia MitchellClaudia Mitchell?

    Universal Cells is a biotechnology company developing regenerative medicine using stem cells that is headquartered in Seattle, Washington and was founded in 2013 by Claudia Mitchell and David Russell. On February 13, 2018 Universal Cells was acquired by Astellas Pharma for an undisclosed amount. 

    Topic: Cofactor GenomicsCofactor Genomics

    A company using RNA to diagnose disease and to develop biomarkers that predict treatment outcomes. Cofactor is founded by Jarret Glasscock.

    • Suggestion Id: 487135

    Would it be accurate and relevant to link the text highlighted below to the topic Paragon (cryptocurrency)Paragon (cryptocurrency)?

    The ImmunoPrism (formerly called Paragon) assay completed validation and certification by the College of American Pathologists (CAP) in 2018. Cofactor’s ImmunoPrism Immune Profiling Kit was launched in 2018, which gives laboratories access to the same kit the company uses for sample preparation, sequencing and analysis of tumor samples. 

    Topic: Fortified BicycleFortified Bicycle

    Company

    • Suggestion Id: 104357

    Would it be accurate and relevant to link the text highlighted below to the topic BostonBoston?

    Fortified Bicycle is a company that participated in the Class 43 - Boston 2014 Fall cohort of Techstars and raised an estimated $1,452,500.

    Topic: Tmunity TherapeuticsTmunity Therapeutics

    Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.

    • Suggestion Id: 487129

    Would it be accurate and relevant to link the text highlighted below to the topic James Riley (gunman)James Riley (gunman)?

    Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases that is headquartered in Philadelphia, Pennsylvania and was founded in 2015 by Carl June, Bruce Levine, Yangbing Zhao, Anne Chew, James Riley, and Bruce Blazar.

    Topic: CRISPR-ChipCRISPR-Chip

    A hand-held device that quickly detects specific genetic mutations by using CRISPR combined with graphene based electronic transistors.

    • Suggestion Id: 487140

    Would it be accurate and relevant to link the text highlighted below to the topic GrapheneGraphene?

    The device analyses purified DNA and gives a report in minutes. The speed comes from the fact that unlike most forms of genetic testing, CRISPR-Chip does not PCR amplify the DNA. The device uses a form of the CRISPR-Cas9 system with a deactivated Cas9 that does not cut. Guide RNA, complementary to the target DNA sequence guides Cas9 to the find exact location in the genome where it binds. In the device Cas9 is tethered to transistors made of graphene, which undergoes a change in electrical conductance when Cas9 binds to the target DNA. The resultant changes in the characteristics of the transistor are detectable in the hand-held device. Graphene is made of a single layer of carbon atoms and is electrically sensitive. In genomic DNA CRISPR-Chip detects a target in 15 minutes with 1.7fM sensitivity.

    Topic: Tissue GenesisTissue Genesis

    Tissue Genesis is a biotechnology company offering enzyme-derived cell therapy processing solutions.

    • Suggestion Id: 487128

    Would it be accurate and relevant to link the text highlighted below to the topic Thomas CannonThomas Cannon?

    Tissue Genesis is a biotechnology company offering enzyme-derived cell therapy processing solutions that is headquartered in Honolulu, Hawaii and was founded in 2001 by Anton Krucky and Thomas Cannon.

    Topic: CRISPR-ChipCRISPR-Chip

    A hand-held device that quickly detects specific genetic mutations by using CRISPR combined with graphene based electronic transistors.

    • Suggestion Id: 487139

    Would it be accurate and relevant to link the text highlighted below to the topic CRISPRCRISPR?

    CRISPR-Chip, the first transistor that uses CRISPR to search the genome for mutations, was developed by researchers at University of California, Berkeley and the Keck Graduate Institute (KGI) of The Claremont Colleges. Their invention was reported in Nature Biomedical Engineering in March, 2019 and assistant professor at KGI is Kiana Aran.